Hyperfine, Inc. HYPR Stock Forecast
AI-powered price prediction and analysis for Hyperfine, Inc. · Alpha · vs marketSwitch to Total
See HYPR's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Hyperfine, Inc.
Hyperfine, Inc. (HYPR) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry.
Latest News
Where HYPR sits on the market map
Electromedical & Electrotherapeutic Apparatus Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| HYPR Hyperfine, Inc. | ▲ | $90M | – |
| MDT Medtronic Plc | ▼ | $118.97B | 22.7x |
| ITGR Integer Holdings Corp | ▼ | $4.30B | – |
| LIVN Livanova Plc | ▼ | $4.21B | 22.3x |
| TMDX Transmedics Group, Inc. | ▶ | $2.74B | 18.1x |
| ECOR Electrocore, Inc. | ▲ | $2.12B | – |
| AXGN Axogen, Inc. | ▲ | $1.94B | – |
| BLFS Biolife Solutions Inc | ▶ | $1.89B | 32.6x |
| CNMD Conmed Corp | ▼ | $1.36B | – |
| CBLL Ceribell, Inc. | ▲ | $1.00B | – |
| INMD Inmode Ltd. | ▶ | $906M | – |
| CV Capsovision, Inc | ▲ | $339M | – |
| ELMD Electromed, Inc. | ▶ | $232M | 20.5x |
| FOCL Edap Tms Sa | ▲ | $158M | – |
| VANI Vivani Medical, Inc. | ▲ | $106M | – |
| STXS Stereotaxis, Inc. | ▲ | $106M | – |
| NRXS Neuraxis, Inc | ▲ | $82M | – |
| OM Outset Medical, Inc. | ▲ | $76M | – |
| POSC Positron Corp | ▶ | $54M | – |
| VASO Vaso Corp | ▲ | $51M | – |
| POCI Precision Optics Corporation, Inc. | ▲ | $50M | – |
| QTI Qt Imaging Holdings, Inc. | ▲ | $36M | – |
| IRIX Iridex Corp | ▲ | $15M | – |
| ITOC Itonic Holdings Ltd | ▼ | $4M | – |
| ADMT Adm Tronics Unlimited, Inc. | ▼ | $3M | – |
| NXL Nexalin Technology, Inc. | ▼ | $2M | – |
| ESMC Escalon Medical Corp | ▶ | N/A | – |
| GTHP Guided Therapeutics Inc | ▲ | N/A | – |
| HCIL Hongchang International Co., Ltd | ▼ | N/A | – |
| NDRA Endra Life Sciences Inc. | ▶ | N/A | – |
| NUWE Nuwellis, Inc. | ▼ | N/A | – |
| YBGJ Yubo International Biotech Ltd | ▼ | N/A | – |
FAQ
Is Hyperfine, Inc. a good stock to buy?
Our AI analyzes Hyperfine, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Hyperfine, Inc. predictions?
A per-ticker accuracy statistic for HYPR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Hyperfine, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Hyperfine, Inc.? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.